<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F714B93F-5F18-424D-B845-C0D078DBC0EB"><gtr:id>F714B93F-5F18-424D-B845-C0D078DBC0EB</gtr:id><gtr:firstName>Stephanie</gtr:firstName><gtr:surname>Kermorgant</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501003"><gtr:id>1DEDC6A8-05C0-4DF2-823A-577084E8A87B</gtr:id><gtr:title>C-Met internalisation and tumour cell migration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501003</gtr:grantReference><gtr:abstractText>Approximately 160,000 people die from cancer every year in the UK alone. Most cancers start as a small lump of abnormal cells (a tumour). As the tumour grows, some cancer cells can detach from the tumour, move away and eventually colonise some healthy part of the body. This aggressive process is called metastasis and is the major cause of treatment failure and the principal cause of death in human cancer. My research focuses on understanding the role of a molecule called c-Met in human cancer metastasis. C-Met is present at the surface of the cells and is activated by binding to its ligand the Hepatocyte Growth Factor (HGF). I want to understand how the activated c-Met transmits signals inside the cancer cell to tell it to move away from the primary tumour. Hopefully this will allow us to design drugs to stop this process. My project is based on the novel concept, for which I already had found evidence, is that surface receptors have to enter into the cell for their correct function and subsequent cell responses. In this project, by using established biochemical approaches, I will block the entry of c-Met into the cancer cell and analyse the consequences of this block on tumour cell movement in vitro and in experimental animals. Using biochemical and biological approaches, including state of the art microscopy, I will follow the movement of c-Met and the generation of signals inside the cell to understand these mechanisms at the molecular level. I will then design ways to inhibit these molecular events in the cell to block cell movement and tumour spread.</gtr:abstractText><gtr:technicalSummary>The aberrant action of growth factor receptors underlies the development and progression of many human tumours. Understanding how these ligands act may provide scope for intervening rationally and increasing the therapeutic index. The current project focuses on understanding the mechanisms of the c-Met receptor in promoting metastasis, the principal cause of death in cancers. This tyrosine kinase receptor and its ligand, Hepatocyte Growth Factor (HGF), are key players in tumour metastasis by modulating cell adhesion, migration, invasion, metalloproteinase activation, cell survival and angiogenesis. Moreover, c-Met is overexpressed in a large number of tumours and activating mutations have been detected in specific cancers. A molecular understanding of how this receptor?s signalling is switched on and off is key to developing rational interventions.
 C-Met stimulates tumour cell migration and invasion through a combination of several downstream signalling pathways. However, how these pathways are integrated in time and space and how some signals are sustained to generate cell motility remains to be determined. There is growing evidence that in response to ligands, receptors remain competent to signal for long periods post-internalisation within endosomal compartments where the nature of the signal outputs may be distinct. In recent work, we provided evidence that c-Met endocytosis sustains key signals involved in c-Met dependent migration. Therefore, the central hypothesis underlying this proposal is that endosomal c-Met signalling is critical in determining the outcome of the tumour cell?s motility response. The aim is to evaluate how c-Met internalisation and subsequent signalling events regulate tumour cell migration and invasion. 
To achieve this objective, c-Met dependent human squamous carcinoma cell migration and invasion will be analysed when c-Met internalisation is impaired. Well established strategies based on the inhibition of clathrin-mediated endocytosis will be used followed by several motility assays both in vitro and in vivo. A combination of biochemical and state of the art microscopy will be employed to investigate the c-Met endocytic signalling pathways involved in cell motility. Eventually, a compartment specific targeting strategy will be investigated to block these signalling pathways in view of developing future novel anti-tumoural and anti-metastatic strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-08</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>323955</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release for a new publication in Nature Communications at Breast Cancer Campaign</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB79D2E4-691C-47BD-8E82-4F8CB3CEF6E0</gtr:id><gtr:impact>Our recent publication in Nature Communications was communicated to the public through press release from one of the funding body that allowed this work to be done, the Breast Cancer Campaign. This article was written mostly in lay language in order to communicate to the wide public the results and impact of our research.

It is expected that, in addition to the scientific community, the general public through getting informed on my research, will gain an increasing awareness of the importance of conducting such research. This likely will impact on increasing fundraising by Breast Cancer Camapaign.</gtr:impact><gtr:outcomeId>546208bc4b4c68.25983765</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.breastcancercampaign.org/articles/publication-signals-a-new-way-of-understanding-how-hard-to-treat-breast-cancer-moves</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for a new publication in Nature Communications at QMUL</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1921EEC8-4680-4A87-82EA-1549467F7FDC</gtr:id><gtr:impact>Our recent publication in Nature Communications was communicated to the public through a press release from the university, QMUL. This article is written in lay language in order to communicate to the general public

It is expected that, in addition to the scientific community, the general public through getting informed on my research, will gain an increasing awareness of the importance of conducting such research within the university</gtr:impact><gtr:outcomeId>546208038c6729.06638553</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.qmul.ac.uk/media/news/items/smd/131902.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute press release for a new publication in Nature Communications</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C1019DED-1584-4782-BD08-5C1A93DB33C6</gtr:id><gtr:impact>Our recent publication in Nature Communications was communicated to the public through press releases from our institute, Barts Cancer Institute. An article was written by our Institute Digital Media and Communications Officer, Marianne Baker, and posted on the External Institute Website. The article is written in a language accessible to the public and is completed with a microscopy picture of cancer cells extracted from the study and with a photography of myself and the post-doctoral researcher, first author on this paper, near a microscope. This article is one of the most popular article on our Webiste.

It is expected that, in addition to the scientific community, the general public through getting informed on my research, gain an increasing awareness of the importance of conducting such research and more generally of the research conducted in our institute and university.</gtr:impact><gtr:outcomeId>5462036b2475b7.61902157</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bci.qmul.ac.uk/news/publications/item/ludo-c-met-rac1-paper-natcommun</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Nursery, Reception and  year 1)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>530F89BA-A3F2-4F91-9D72-F2B6ADA74880</gtr:id><gtr:impact>I have been invited to talk to children of a local nursery (30 children 2-5) and of a local school (around 180 children in total from 2 x nursery, 2 x reception and 2 x year 1 classes) to explain what is being a scientist. Each session lasted around 30 minutes. I have done 4 sessions in total.
I wore may lab coat, brought some tools and showed a few slides. The children were very engaged and asked me a lot of questions.</gtr:impact><gtr:outcomeId>58c16d402dc841.75684784</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Photo shoots for Bristish Lung Fundation</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F4BE9F67-A184-4100-BB27-C032B119DA94</gtr:id><gtr:impact>Most of the pictures appearing in the last BLF report booklet aiming in informing the public about BLF activities, Changing lives 2013-2014, are members of my team working in the laboratory.

It is expected that this activity will increase BLF fundraising and the general public awareness of the importance of performing research related to lung disease</gtr:impact><gtr:outcomeId>54620f833801e4.01648090</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.blf.org.uk/Page/Changing-Lives</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Training for Local A level students</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>154F026D-B51B-4BD7-98D7-40873BCBF5E7</gtr:id><gtr:impact>One of my PhD student participated in the training of laboratory skills ans techniques of A levels local students, coming from local public schools.</gtr:impact><gtr:outcomeId>58c1711cddcf17.69980319</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.bci.qmul.ac.uk/public-engagement/bci-stars</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Coverage of a new research funding</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EC1AF76B-4B94-4B75-8317-8FDCA5628203</gtr:id><gtr:impact>A study we published in Nature Communications in June 2016, revealing a new mechanism used by cancer cells to survive when detached (metastasis), opening new avenues of investigations for future cancer treatment, has attracted much attention from the media. 
The work was covered in more than 77 media including at least 8 UK publications, many international media including from Spain, United States, Australia, Ireland, Germany and Vietnam, Global media (International Business Times, New Atlas (formerly Gizmag), as well as in specialist outlets (eCancer News, Tech Times, Drug Discovery &amp;amp; Development, Biotech Magazine).
I as interviewed by the Evening Standard, following an article relating my discovery (on the day the scientific article was published), with my picture in the lab as well as one of my microscopy picture of a cancer cell. This article has been seen by many people, scientists or not, such as neighbours. It lead to many discussion about my work with the general public and I believe, increased the awareness of research in biology and medicine to the general public. 
I was also interviewed by Medical Research and my interview can be found here: http://medicalresearch.com/author-interviews/membrane-molecules-help-drive-cancer-metastases/25461/
My paper was also referred in the Medical Research Council Biomedical Picture of the Day.
http://bpod.mrc.ac.uk/archive/2016/8/27


These occurred following QMUL's press release 'Unexpected findings reveal insight into how cancer spreads in the body' and accompanying animation video that was produced by BCI &amp;amp; Phospho Biomedical animations.
The article in Wired.co.uk generated a huge amount of traffic for this video, which now has over 148,000 views on BCI's channel - it is also hosted on Phospho's channel, where it has over 14,500 views. The publication had an altmetric score of 224 in 2016, ranking it in the top 5% publications.
I was finalist at our University Engagement and Enterprise Awards 2017 (Media categories).</gtr:impact><gtr:outcomeId>58c16b614a4e34.30559005</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.qmul.ac.uk/media/news/items/smd/178304.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Course for cancer patients to show research in the laboratory-VOICE</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AD698CD8-C60A-48DA-9E92-2B1EE6DC80B9</gtr:id><gtr:impact>One of my PhD student and my post-doc have taken part in this course organised with the charity VOICE, to share their day to day work in the lab with cancer patients and carers</gtr:impact><gtr:outcomeId>58c16f4e208985.81424304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.bci.qmul.ac.uk/public-engagement/voice-course</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation at an international conference in the US</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A96A3E0F-D22E-43BB-9572-FD9B23AD02BC</gtr:id><gtr:impact>I was an invited speaker at the 2017 Gordon Research Conference Fibronectin, Integrins &amp;amp; Related Molecules, Ventura, California, US</gtr:impact><gtr:outcomeId>58c171f0ae88c6.94911443</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.grc.org/programs.aspx?id=11305</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>184882</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:fundingRef>472/1711</gtr:fundingRef><gtr:id>72A02046-69BB-4FEA-A8A1-B78FB0DB7576</gtr:id><gtr:outcomeId>VpDKD4UqHMg</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>131449</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical PhD studentship</gtr:description><gtr:end>2020-08-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:id>241D76B2-A660-4F31-BD4D-26FDF2A0C271</gtr:id><gtr:outcomeId>58c1607798e706.09010416</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Continuation grant</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>652AC00D-1C34-497C-90D7-462854D0FE4D</gtr:id><gtr:outcomeId>56e04ea9b1f8d7.39637913</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>143328</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>2A5BDC04-070D-4082-9237-958C7367787F</gtr:id><gtr:outcomeId>985C2A36BD20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>41D8DEF0-663A-4916-9234-EBB8BA0A9DE7</gtr:id><gtr:outcomeId>E0FD7D8DAF50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7D663604-221E-4A1F-8885-52114D15EAB1</gtr:id><gtr:outcomeId>AHdcs9hFM5p</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Post-doc Fellowship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:fundingRef>M314</gtr:fundingRef><gtr:id>8AE08F94-48A6-4D5C-AEF3-630D8E5FA020</gtr:id><gtr:outcomeId>cK9nm77K9N7</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LiDo-BBSRC PhD studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>54CDF3CF-0492-44C4-93D9-DA5C3D75B548</gtr:id><gtr:outcomeId>58c15e97c02031.52354627</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:fundingRef>M314F2</gtr:fundingRef><gtr:id>30BE585C-4AA4-4EF8-A591-7AD03698EA88</gtr:id><gtr:outcomeId>58c15f7c04a790.80147745</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Pancreatic Cancer UK</gtr:fundingOrg><gtr:id>C0176522-E5C3-4BB5-8E9A-521F665DE72D</gtr:id><gtr:outcomeId>56e03979c45594.82962582</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56431</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centenary Award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1FEB46CC-F483-4AFB-B226-EEB1A319989D</gtr:id><gtr:outcomeId>nr1b6R7a6KG</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pilot Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Breast Cancer Campaign (BCC)</gtr:fundingOrg><gtr:fundingRef>2013NovSP224</gtr:fundingRef><gtr:id>AAB3C0EA-FD8E-4CB4-9DAC-1454FE059246</gtr:id><gtr:outcomeId>545b799db7d767.96807828</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>185593</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Breast Cancer Campaign (BCC)</gtr:fundingOrg><gtr:fundingRef>2008NovPR10</gtr:fundingRef><gtr:id>5F9ACB31-5E32-46D0-B399-1E19DBE4E28F</gtr:id><gtr:outcomeId>C10D8BBAC410</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>F80E52AD-FCF3-419D-8B1F-18E95336E1F0</gtr:id><gtr:outcomeId>Smnh8rdWD8j0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Pancreatic Cancer Research Fund</gtr:fundingOrg><gtr:id>D133A91B-8289-4F5F-8547-FEE33931F0C2</gtr:id><gtr:outcomeId>545b7a1949aef7.38845025</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>development of assays to study receptor internalisation and recycling</gtr:description><gtr:id>21BEF889-242D-4B76-BBD5-E1CE872B6D4D</gtr:id><gtr:impact>in the department, other groups now use this technique.
We have a method paper in press (Methods in Enzymology 2014, Volume 535, Chapter 8, 2014, in press)</gtr:impact><gtr:outcomeId>16761C0C316</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Trafficking assays</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CB8F42FD-AF92-4B0A-A27F-29087EEB8FD9</gtr:id><gtr:title>PKC and the control of localized signal dynamics.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4612d32fc4cb17669eaf2e15194f5eb3"><gtr:id>4612d32fc4cb17669eaf2e15194f5eb3</gtr:id><gtr:otherNames>Rosse C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>dPBHbfMQkM6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75F07AC8-D30F-4D30-98AF-94508E83738C</gtr:id><gtr:title>Anomalous inhibition of c-Met by the kinesin inhibitor aurintricarboxylic acid.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3da0f4c467b3c9e78cf4d589da98feab"><gtr:id>3da0f4c467b3c9e78cf4d589da98feab</gtr:id><gtr:otherNames>Milanovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>pm_14997_27_21400516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9811813A-6CED-449E-A5BA-00A556E2B8CD</gtr:id><gtr:title>Vesicle Trafficking in Cancer</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4941579dbfa0a907432405dd820a6d35"><gtr:id>4941579dbfa0a907432405dd820a6d35</gtr:id><gtr:otherNames>Joffre C, Barrow R, Menard L, Kermorgant S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-1-4614-6528-7</gtr:isbn><gtr:outcomeId>it8babvPPgg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55757EB1-D01C-47D2-B183-E7BCD9BE2865</gtr:id><gtr:title>Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/952fe05a1957d59b2702180330426d7c"><gtr:id>952fe05a1957d59b2702180330426d7c</gtr:id><gtr:otherNames>Kermorgant S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>F18AD73D24F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33C34BA6-377A-403E-9007-35EB8F050306</gtr:id><gtr:title>ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8822d1bee5b270b3b94703795bf1706b"><gtr:id>8822d1bee5b270b3b94703795bf1706b</gtr:id><gtr:otherNames>Radtke S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14997_27_23549785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1B5B1AA-AEB0-4429-B4B2-66C22E91A23E</gtr:id><gtr:title>Measuring the role for Met endosomal signaling in tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7df8295f4a90c61f0ae3748372a50b9"><gtr:id>d7df8295f4a90c61f0ae3748372a50b9</gtr:id><gtr:otherNames>Barrow R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-0-12-397925-4</gtr:isbn><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>Xj6ked6mSTd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF60C080-ABF1-4332-A037-BDDDD99B8DB3</gtr:id><gtr:title>The clinical and functional significance of c-Met in breast cancer: a review.</gtr:title><gtr:parentPublicationTitle>Breast cancer research : BCR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7baa851d299183c6eeddbfc01b63641"><gtr:id>c7baa851d299183c6eeddbfc01b63641</gtr:id><gtr:otherNames>Ho-Yen CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-5411</gtr:issn><gtr:outcomeId>56e038141f7948.16668135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC9AD80E-D302-43CB-8387-73BDE2D05024</gtr:id><gtr:title>Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/660305fa92a9e0d3cf4b20bff1475fb2"><gtr:id>660305fa92a9e0d3cf4b20bff1475fb2</gtr:id><gtr:otherNames>Reynolds LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>VfhGGx3jqLV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3C61DB2-7042-46CC-B444-983F0FA3B714</gtr:id><gtr:title>Distinct c-Met activation mechanisms induce cell rounding or invasion through pathways involving integrins, RhoA and HIP1.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e11befc4d7908d33ccd4324651a51"><gtr:id>a32e11befc4d7908d33ccd4324651a51</gtr:id><gtr:otherNames>Mai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>545b7805b7e4a3.78336478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E984C80-771B-4BCC-9DAD-488FDB2DC74D</gtr:id><gtr:title>Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c65a42542cc266df2d767e01c87b5692"><gtr:id>c65a42542cc266df2d767e01c87b5692</gtr:id><gtr:otherNames>Ho-Yen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_14997_27_23674084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C3F0F33-8CDF-46D5-A140-E3A340A5CAA0</gtr:id><gtr:title>Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a8193f3a0c81ae7c13cad9f330f8167"><gtr:id>9a8193f3a0c81ae7c13cad9f330f8167</gtr:id><gtr:otherNames>M?nard L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>545b7805e0d623.06811873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E9D64CD-3E61-459D-8395-FAA1B90E8D7B</gtr:id><gtr:title>C-Met in invasive breast cancer: is there a relationship with the basal-like subtype?</gtr:title><gtr:parentPublicationTitle>Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7baa851d299183c6eeddbfc01b63641"><gtr:id>c7baa851d299183c6eeddbfc01b63641</gtr:id><gtr:otherNames>Ho-Yen CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-543X</gtr:issn><gtr:outcomeId>pm_14997_27_24150964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>887EB3DA-E286-4B6C-ACEC-F0A874053AC0</gtr:id><gtr:title>A direct role for Met endocytosis in tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/818c570a83e311bfa13dc6de12ac8e81"><gtr:id>818c570a83e311bfa13dc6de12ac8e81</gtr:id><gtr:otherNames>Joffre C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>Vbws93gXx4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D7CFEF0-06EE-4C95-A8B5-F7BF4D6890A7</gtr:id><gtr:title>Met endosomal signalling: in the right place, at the right time.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea077a7cd7f36941c05044cd3de1db7e"><gtr:id>ea077a7cd7f36941c05044cd3de1db7e</gtr:id><gtr:otherNames>Barrow-McGee R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>545b78059073f9.82232355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E34FA1A-D1B1-49F7-9CDA-45F5661B6A4A</gtr:id><gtr:title>Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea077a7cd7f36941c05044cd3de1db7e"><gtr:id>ea077a7cd7f36941c05044cd3de1db7e</gtr:id><gtr:otherNames>Barrow-McGee R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d65c9160b03.09771875</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501003</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>